SCHEMBL8735778

SCHEMBL8735778

Oc1ccc2[c]c(-c3ccccc3O)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 6/20 0.53
CYP1A2 P05177 2/20 0.42
ESR1 P03372 5/20 0.37
ALOX5 P09917 1/20 0.35
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALOX15 P16050 2/20 0.34
TP53 P04637 1/20 0.34
HSP90AA1 P07900 1/20 0.34
CYP3A4 P08684 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501303 0.82 ALDH1A1 (0.39) ESR2CYP1A2HPGDHSD17B10ALDH1A1
SCHEMBL9396526 0.82 CYP1A2 (0.44) ESR2CYP1A2ESR1HSD17B10ALOX15
SCHEMBL10594294 0.79 ESR2 (0.52) ESR2CYP1A2ESR1ALOX5HPGD
SCHEMBL3636461 0.75 ESR1 (0.50) ESR2CYP1A2ESR1CYP3A4CYP2D6
SCHEMBL8734007 0.75 HSD17B1 (0.55) ESR2CYP1A2ESR1CYP3A4CYP2D6
SCHEMBL21385240 0.71 CYP1A2 (0.52) ESR2CYP1A2ESR1ALOX5HSD17B10
SCHEMBL5030675 0.70 CYP1A2 (0.44) ESR2CYP1A2ESR1HSD17B10ALOX15
SCHEMBL8777379 0.70 CYP1A2 (0.44) ESR2CYP1A2ESR1HSD17B10ALOX15
SCHEMBL3016027 0.69 ESR2 (1.00) ESR2CYP1A2ESR1ALOX5HPGD
SCHEMBL28461364 0.67 HPGD (0.41) ESR2ESR1ALOX5HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0826680-A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods ELI LILLY AND COMPANY (US) 1998-03-04 EP disclosed